Future
Future directions and AI
Vestibular imaging is changing on five fronts at once: AI-augmented interpretation, higher-resolution MRI sequences, imaging-guided intratympanic therapy, hybrid PET-MRI, and portable point-of-care imaging. None replaces clinical judgment, but each shifts what the clinician can reasonably expect from the radiology suite.
AI and machine learning in interpretation
Artificial intelligence — most often deep convolutional neural networks trained on labelled image archives — is starting to flag features radiologists miss, particularly in the time-pressured acute stroke pathway.
The most plausible near-term wins are in three areas:
- Acute posterior-fossa stroke triage — flagging subtle DWI changes during the false-negative window, with the human radiologist retaining final interpretation.
- Vestibular schwannoma detection and segmentation — for serial surveillance, automated volume measurement matters more than human measurement for tracking growth.
- Multiple sclerosis lesion burden quantification — automated 3D-FLAIR plaque segmentation supports treatment response monitoring.4
The figure below is a toy classifier illustrating the nearest-cluster reasoning at the core of these systems. Drag the probe across the feature space to see how confidences shift with proximity to each cluster centroid.
The realistic clinical mode is human-AI partnership. AI is fast at flagging candidate findings; clinicians are slow but contextually rich. Deployments that play to both strengths — AI as a triage assistant, radiologist as final arbiter — are emerging in stroke pathways at major centres. Watch the false-positive rate as carefully as the sensitivity gain; over-flagging erodes trust faster than it saves time.
An illustrative classifier
This is a deliberately simple visualisation: three labelled clusters in a 2D feature space, with a draggable probe. Real systems operate in much higher dimensions on features learned by deep networks — but the decision-boundary intuition is the same.
Advanced MRI sequences
DTI quantifies white-matter integrity along vestibulospinal and medial longitudinal fasciculus tracts, exposing microstructural change in multiple sclerosis and chronic vestibulopathy before structural lesions appear. 3D-FLAIR at higher field strengths sharpens detection of small posterior-fossa lesions. Inner- ear protocols continue to evolve, particularly for hydrops imaging.1
Imaging-guided intratympanic therapy
Intratympanic corticosteroid or gentamicin is now standard care in selected Ménière’s and sudden SNHL cases. MRI with gadolinium-based agents can visualise drug distribution in perilymph after intratympanic delivery, allowing pharmacokinetic study and patient-specific dose adjustment.1
Hybrid PET-MRI
One acquisition, both metabolic and structural / functional data in the same coordinate frame. The most promising use in vestibular disease is in chronic functional dizziness — correlating PIVC metabolism with structural connectivity in one session.3
Portable and point-of-care imaging
Portable low-field MRI is feasible at the bedside in critical-care settings.2For vertigo specifically, the acute application is faster exclusion of large posterior-fossa stroke in environments where access to conventional MRI is hours away. Image quality is lower than 1.5 T or 3 T, but in the right pathway it shortens the diagnostic loop substantially.
What is unlikely to change
- HINTS at the bedside will remain the cheapest sensitive test for central AVS.
- Classic BPPV will remain a clinical diagnosis treated by Epley, without imaging.
- The need to ask the clinical question before the imaging question will not be automated away.
Closing
Imaging will continue to become more precise, more accessible, and more closely integrated with clinical decision-support. The principles, however, will not change: image when imaging will change management; choose the modality that answers the clinical question; and interpret the result alongside the bedside, never instead of it.